Sales/Maturities of Investments

$2.42B

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$2.42Bperiod endingJun 30, 2026

VRTX Quarterly Sales/Maturities of Investments ($0.00 → $2.42B)

Quarterly Sales/Maturities of Investments

High-resolution chart · PNG

VRTX sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Sales/Maturities of Investments — Quarterly (USD)
Period ending	Sales/Maturities of Investments (USD)
Jun 30, 2001	237,261,000
Mar 31, 2001	195,168,000
Dec 31, 2000	882,905,000
Sep 30, 2000	83,580,000
Jun 30, 2000	58,159,000
Mar 31, 2000	63,938,000
Dec 31, 1999	85,000,000
Sep 30, 1999	76,600,000
Jun 30, 1999	100,400,000
Mar 31, 1999	166,900,000
Dec 31, 1998	494,800,000
Sep 30, 1998	0
Jun 30, 1998	0
Mar 31, 1998	700,000
Dec 31, 1997	0
Sep 30, 1997	0
Jun 30, 1997	0
Mar 31, 1997	0
Dec 31, 1996	0
Sep 30, 1996	0
Jun 30, 1996	5,800,000
Mar 31, 1996	1,300,000
Dec 31, 1995	0
Sep 30, 1995	0
Jun 30, 1995	0
Mar 31, 1995	0
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0
Dec 31, 1993	2,600,000
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	6,700,000
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0
Dec 31, 1991	0
Sep 30, 1991	0